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Abstract
© 2018 Ekaterina  V.  Martynova  et  al.  Kidney  insufficiency  is  a  hallmark  of  nephropathia
epidemica (NE). Little is known about the mechanisms of the NE kidney pathology, with current
knowledge mainly based on findings in postmortem tissue. We have analyzed kidney damage
biomarkers in urine collected from early- and late-phase NE using Bio-Plex kidney toxicity panels
1 and 2. To determine the disease specificity, kidney damage biomarkers were also analyzed in
urine  samples  from  patients  diagnosed  with  gout,  type  2  diabetes,  systemic  lupus
erythematosus, and chronic kidney insufficiency. Analysis of 12 biomarkers suggests damage to
the kidney proximal tubule at the onset of NE. Also, upregulation of biomarkers of inflammation
and leukocyte chemotaxis were detected in NE urine. Furthermore, increased clusterin levels
were found in early- and late-phase NE urine. Comparative analysis revealed that clusterin is a
biomarker, upregulated in NE urine.
http://dx.doi.org/10.1155/2018/8658507
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